Published in Dig Dis on October 29, 1996
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One (2008) 1.12
NERD, GERD, and Barrett's esophagus: role of acid and non-acid reflux revisited with combined pH-impedance monitoring. Dig Dis Sci (2008) 0.97
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid. Br J Cancer (2000) 0.83
Role of p53 assessment in management of Barrett's esophagus. Dig Dis Sci (1999) 0.80
CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer. Br J Cancer (2005) 0.78
Adenocarcinoma of the esophagus: preventable but at what cost? Dig Dis (1996) 0.75
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Management of esophageal perforation. Am J Surg (1980) 1.90
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64
Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg (1992) 1.64
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2008) 1.61
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg (1999) 1.60
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58
Cystic and bullous lung disease. Ann Thorac Surg (1991) 1.55
Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis (1997) 1.54
Immunosuppression in patients with Barrett's esophagus. Surgery (1992) 1.54
Potentially curable cancer of the esophagus. Cancer (1982) 1.53
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53
The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. Surg Clin North Am (1976) 1.52
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg (1996) 1.49
Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg (1985) 1.48
Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. Am J Gastroenterol (1994) 1.48
Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48
Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery (1989) 1.44
Interaction of lower esophageal sphincter pressure and length of sphincter in the abdomen as determinants of gastroesophageal competence. Am J Surg (1982) 1.42
Drug-induced esophageal strictures. Ann Surg (1987) 1.40
Pharyngoesophageal dysfunctions. The role of cricopharyngeal myotomy. Arch Surg (1985) 1.39
Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg (2000) 1.39
Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery (1992) 1.38
Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg (1993) 1.38
Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery (1997) 1.37
Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9. Arch Surg (2001) 1.37
Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg (1994) 1.35
Relationship of a hiatal hernia to the function of the body of the esophagus and the gastroesophageal junction. J Thorac Cardiovasc Surg (1981) 1.34
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33
Midgut nonrotation in adults. An aggressive approach. Am J Surg (1975) 1.32
The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg (1999) 1.29
Gastroesophageal reflux in achalasia. When is reflux really reflux? Dig Dis Sci (1997) 1.28
A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg (2009) 1.26
Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg (1999) 1.26
Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy. Surgery (1979) 1.25
Risk factors and the prevalence of trocar site herniation after laparoscopic fundoplication. Surg Endosc (2001) 1.25
Reasons for conversion from laparoscopic to open cholecystectomy in an urban teaching hospital. Am J Surg (1994) 1.24
Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication. Ann Surg (1989) 1.24
DNA methylation: an alternative pathway to cancer. Ann Surg (2001) 1.24
Three-dimensional pressure image and muscular structure of the human lower esophageal sphincter. Surgery (1995) 1.24
Alkaline gastroesophageal reflux. Am J Surg (1978) 1.23
Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux. Dig Dis Sci (1981) 1.22
Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg (1999) 1.21
Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg (1993) 1.21
Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg (1980) 1.21
Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model. Surg Endosc (2001) 1.19
Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol (1994) 1.17
Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery (1987) 1.17
Duodenogastric reflux and reflux esophagitis. Surgery (1984) 1.16
Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg (1994) 1.14
Three-dimensional imaging of the lower esophageal sphincter in gastroesophageal reflux disease. Ann Surg (1991) 1.14
Endoscopic signs for gastroesophageal reflux objectively evaluated. Gastrointest Endosc (1976) 1.14
Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg (1989) 1.13
Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg (1994) 1.11
Sequential staging in bronchogenic carcinoma. Chest (1979) 1.11
A tailored approach to antireflux surgery. J Thorac Cardiovasc Surg (1995) 1.08
Evaluation of the Nissen antireflux procedure by esophageal manometry and twenty-four hour pH monitoring. Am J Surg (1975) 1.08
The effect of heterologous anti-lymphocyte seerum on mouse hemopoietic stem cells. J Exp Med (1968) 1.07
The impact of a dedicated trauma program on outcome in severely injured patients. Arch Surg (1995) 1.06
Circadian esophageal motor function in patients with gastroesophageal reflux disease. Surgery (1990) 1.06
Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg (2001) 1.04
The role of the esophageal body in the antireflux mechanism. Surgery (1982) 1.04
Effect of Nissen fundoplication on esophageal motor function. Arch Surg (1992) 1.04
The role of fundoplication in the treatment of type II paraesophageal hernia. J Thorac Cardiovasc Surg (1996) 1.04